Genomic Vision announced Thursday that it has entered into an exclusive distribution agreement with French SME CliniSciences to accelerate the commercialization of its products in Europe.

The biotech company, which specializes in genome modification tools, says the agreement will give it access to CliniSciences' distribution channels and customer base in over 15 European countries.

The partnership will not only enhance the company's ability to improve biomanufacturing standards, but also promote the advancement of advanced cell and gene therapies.

Outside Europe, Genomic Vision plans to continue marketing its products and services independently.

Listed on the Paris Bourse, Genomic shares gained 1.5% on Thursday in the wake of the announcement.

Copyright (c) 2023 CercleFinance.com. All rights reserved.